News
Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer ...
Among liquid biopsy–based methodologies, cell-free DNA (cfDNA)–related early diagnosis technology is relatively mature, and relevant commercial detection kits have been approved. 8 The main ...
Development and Validation of a Cell-Free DNA Fragmentomics–Based Model for Early Detection of Pancreatic Cancer The following represents disclosure information provided by authors of this manuscript.
A random sampling of cell-free DNA will consist of DNA from all chromosomes in proportion to their size—the largest chromosome being represented by the most segments, and so on—and therefore ...
This includes a late 2026-to-early-2027 release date and a price north of $2,000. That high price tag could be even higher, as Kuo ambiguously writes that it will be “above $2,000 and $2,500 ...
Donor-derived cell-free DNA can aid detection, diagnosis, and monitoring of antibody-mediated rejection after kidney transplantation.
Aldevron unveiled Alchemy™ cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to ...
Myriad Genetics' research allows prenatal cell-free DNA screening as early as eight weeks gestation, a significant advancement in prenatal genetic testing.
Aldevron’s Alchemy™ is an exclusive cell-free DNA technology which cuts research grade linear DNA manufacturing time by over 50 percent, accelerating mRNA development projects with cleaner ...
Recently, cell-free DNA (cfDNA) fragmentomic features, which encompass fragment size, end motifs, breakpoint motifs, and nucleosome footprints, have demonstrated the potential of cfDNA fragmentomics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results